Search

Your search keyword '"Lombardi, Gemma"' showing total 230 results

Search Constraints

Start Over You searched for: Author "Lombardi, Gemma" Remove constraint Author: "Lombardi, Gemma"
230 results on '"Lombardi, Gemma"'

Search Results

51. Design and implementation of a Stroke Rehabilitation Registry for the systematic assessment of processes and outcomes and the development of data-driven prediction models: The STRATEGY study protocol

52. Comparison of arterial spin labeling registration strategies in the multi‐center GENetic frontotemporal dementia initiative (GENFI)

53. Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study

55. Assessing Relationships between Physically Demanding Work and Late-Life Disability in Italian Nonagenarian Women Living in a Rural Area

56. Corrigendum to “Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study” [Neurobiology of Aging Volume 108, December 2021, Pages 155–167]

57. The CBI-R detects early behavioural impairment in genetic frontotemporal dementia

58. Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis

59. Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study

60. Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia

61. Predictors of Mortality in 433 Nonagenarians Inside the Mugello Study: A 10 Years Follow-Up Study

62. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia

63. Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers

64. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

65. Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia

66. Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study

67. CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia

69. Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort

70. Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study

72. Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements

73. Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder

74. The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint

75. Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort

76. Education modulates brain maintenance in presymptomatic frontotemporal dementia

77. MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia

79. The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort

80. Differential early subcortical involvement in genetic FTD within the GENFI cohort

81. Error in Article Information

82. Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia

83. Impairment of episodic memory in genetic frontotemporal dementia

84. Association of rs3027178 polymorphism in the circadian clock gene PER1 with susceptibility to Alzheimer's disease and longevity in an Italian population

85. Impairment of episodic memory in genetic frontotemporal dementia:A genfi study

87. Matching Clinical Diagnosis and Amyloid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia

88. Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer’s Disease Reveals Sex Differences

89. Analysis of Feasibility, Adherence, and Appreciation of a Newly Developed Tele-Rehabilitation Program for People With MCI and VCI

90. Challenges in Alzheimer’s Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences

91. Concordance among neuropsychological profile, functional neuroimaging and pathological biomarkers in Primary Progressive Aphasia. A single-centre experience (675)

92. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment

93. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

94. White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort

95. Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia

96. Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F‐fluorodesoxyglucose‐positron emission tomography.

99. Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study

100. Clinical and neuroimaging profiles to identify C9orf72 ‐FTD patients and serum Neurofilament to monitor the progression and the severity of the disease

Catalog

Books, media, physical & digital resources